col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


137 Results       Page 1

 [1] 
Elsevier: Transfusion and Apheresis Science
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―14 Can SARS-CoV-2 Infection Cause Prolonged Pseudothrombocytopenia? A Case Presentation and Literature Summary Unal Atas, Mustafa Sinanoglu, Volkan Karakus
2 [GO] 2023―Aug―12 Long-term antibody titers variation in unvaccinated patients receiving convalescent plasma or placebo for severe SARS-CoV-2 pulmonary infection. Paula Scibona, Leandro Daniel Burgos Pratx, Nadia Savoy, Delfina Recart, Yasmin Elia, Facundo Nahuel Seoane, et al. (+10)
3 [GO] 2023―Jun―16 AUTOLOGOUS VERSUS ALLOGENEIC BLOOD TRANSFUSION: A COMPARATIVE STUDY OF THE PERI-OPERATIVE OUTCOMES IN A TERTIARY CARE HOSPITAL IN SOUTH INDIA AMIDST THE COVID-19 PANDEMIC Angel Mary Sam, Debasish Gupta, Amita Radhakrishnan, Manikandan Sethuraman, Prasanta Kumar Dash, Shivanesan Pitchai, Krishnakumar Kesavapisharady
4 [GO] 2023―May―08 Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans? Olivier Garraud, Hervé Watier
5 [GO] 2023―Apr―13 A Case of Hyperhemolysis Syndrome in Sickle Cell Disease and Concomitant COVID-19 Allen Green, Heather Jones, Alecia Nero, Ibrahim F. Ibrahim, Ravi Sarode, Lisa M. Scheid, et al. (+3)
6 [GO] 2023―Mar―29 Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: report from a single center Sabrina Giammarco, Simona Sica, Elisabetta Metafuni, Maria Assunta Limongiello, Caterina Giovanna Valentini, Federica Sorà, et al. (+4)
7 [GO] 2023―Mar―20 The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan Ayumi Kamo-Imai, Tomiteru Togano, Motohiko Sato, Yuiko Kawakami, Kumi Inaba, Hiroshi Shimazu, et al. (+11)
8 [GO] 2023―Mar―11 Effects of Cytokine Hemadsorption as Salvage Therapy on Common Laboratory Parameters in Patients with Life-threatening COVID-19 Serhat Uysal, Mustafa Merter, Ayşe Uysal, Ayhan Akbulut
9 [GO] 2023―Mar―04 Assessment of the impact of pathogen reduction technologies on the neutralizing activity of COVID-19 convalescent plasma. Salwa Hindawi, Tarek Elgemmezi, Sherif El-Kafrawi, Hani Samadani, Myasin Tilmisani, Omar Assiri, et al. (+3)
10 [GO] 2023―Feb―25 Nurses perspective of apheresis in SARS-CoV-2 infected patients Linda Tjoelker en Hans Vrielink
11 [GO] 2023―Jan―31 POLYCLONAL IMMUNOGLOBULINS FOR COVID-19 PRE-EXPOSURE PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS Daniele Focosi, Massimo Franchini
12 [GO] 2022―Dec―29 Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma Makoto Inada, Tomiteru Togano, Mari Terada, Katsuyuki Shiratori, Shinya Tsuzuki, Yuki Takamatsu, et al. (+7)
13 [GO] 2022―Dec―17 Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes Jean AMIRAL, Jerard Seghatchian
14 [GO] 2022―Nov―03 Apheresis and COVID-19 Xanthi Zikou, Vasiliki Polychronidou, Stavros Aloizos
15 [GO] 2022―Nov―01 IMMUNOADSORPTION AND COVID 19 PANDEMIC Paraskevi Tseke, Ioannis Griveas
16 [GO] 2022―Nov―01 Apheresis and COVID-19 in intensive care unit (ICU) Zikou Xanthi, Polychronidou Vasiliki, Aloizos Stavros
17 [GO] 2022―Oct―28 Effectiveness of Hemoperfusion (HP) in hemodialysis (HD) patients with Covid-19 infection Ioannis Griveas
18 [GO] 2022―Oct―28 Soluble Urokinase Plasminogen Activator Receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection Ioannis Griveas, Evaggelos Pratilas
19 [GO] 2022―Sep―12 Acquired hemophilia A following COVID-19 vaccination - The importance of prompt diagnosis: A case report Andrea Duminuco, Marianna Calagna, Uros Markovic, Benedetta Esposito, Stephanie Grasso, Carla Riccobene, et al. (+2)
20 [GO] 2022―Sep―06 Exploring the unseen effect of COVID 19 pandemic on blood transfusion services in a tertiary care centre Paramjit Kaur, Ravneet Kaur Bedi, Kshitija Mittal, Tanvi Sood
21 [GO] 2022―Aug―30 Screening for antibodies to HLA class I in apheresis donors following Covid-19 or SARS-CoV-2 vaccination Lise Sofie H Nissen-Meyer, Elzbieta Czapp, Christian Naper, Tore Jensen, Line M L Boulland
22 [GO] 2022―Aug―26 Analysis of the IgG subclass profile and IgG sum-total discrepancy in COVID-19 convalescent plasma donors: A single-centre prospective cohort study Tomasz Wasiluk, Magdalena Sredzinska, Anna Rogowska, Agnieszka Zebrowska, Barbara Boczkowska-Radziwon, Anna Stasiak-Barmuta, Piotr Radziwon
23 [GO] 2022―Aug―04 Rethinking the role of COVID-19 convalescent plasma in the critically ill Arturo Casadevall, Liise-anne Pirofski
24 [GO] 2022―Jul―01 CONVALESCENT PLASMA- AN INSIGHT INTO A NOVEL TREATMENT OF COVID-19 ICU PATIENTS Mohit Chowdhry, Maryam Hussain, Prachi Singh, Minu Lekshmi, Soma Agrawal, MS Kanwar, et al. (+8)
25 [GO] 2022―Jun―14 SARS-CoV-2 and Cancer: The intriguing and informative cross-talk Hadi Goubran, Julie Stakiw, Jerard Seghatchian, Gaafar Ragab, Thierry Burnouf
26 [GO] 2022―Jun―11 COVID-19 convalescent plasma: current status, lessons from the past and future perspectives Tor Audun Hervig, Øystein Flesland, Lise Sofie Haug Nissen-Meyer
27 [GO] 2022―Jun―11 Can plasma exchange therapy be an option for the treatment of SARS-CoV-2 Related Splenial Lesion Syndrome: Two cases from the pediatric intensive care unit Fatih Varol, Nese Ergul, Ebru Guney Sahin, Yasar Yusuf Can, Umut Ergul, Sirin Guven, Halit Cam
28 [GO] 2022―May―21 Platelet and extracellular vesicles in COVID-19 infection and its vaccines Hadi Goubran, Jerard Seghatchian, Waleed Sabry, Gaafar Ragab, Thierry Burnouf
29 [GO] 2022―May―11 Effect of Convalescent Plasma therapy on Mortality in Moderate-to-Severely Ill COVID-19 Patients Akanksha Agrawal, Tanvi Jha, Priyanka Gogoi, Preeti Diwaker, Ashish Goel, Amir Maroof Khan, Ashok Kumar Saxena
30 [GO] 2022―May―10 Human Placenta-derived Mesenchymal Stromal Cells Transfusion in a Critically Ill Infant Diagnosed with Coronavirus Disease 2019 (COVID-19): A Case Report Mehrdad Payandeh, Reza Habibi, Amir Hossein Norooznezhad, Zohreh Hoseinkhani, Feizollah Mansouri, Reza Yarani, et al. (+4)
31 [GO] 2022―Apr―11 ABO and Rh blood groups, demographics, and comorbidities in COVID-19 related deaths: A retrospective study in Split-Dalmatia County, Croatia Ivan Brdar, Ivan Jerković, Željana Bašić, Nenad Kunac, Deny Anđelinović, Joško Bezić, et al. (+3)
32 [GO] 2022―Apr―09 Is SARS-CoV-2 screening still necessary before hematopoietic stem cell donation? Observations from a single center and review of the literature Roberto Crocchiolo, Elisabetta Volpato, Laura Bellio, Irene Cuppari, Gabriele Magliano, Beatrice De Marco, et al. (+2)
33 [GO] 2022―Apr―01 Impact of COVID-19 on the efficacy of meeting the transfusion demand by a Brazilian blood banks network Daniela de Oliveira Werneck Rodrigues, Nathalia Noyma Sampaio Magalhães, Maria Clara Fernandes Silva-Malta, Daniel Gonçalves Chaves, Ricardo Villas Freire de Carvalho, Maisa Aparecida Ribeiro, et al. (+2)
34 [GO] 2022―Mar―23 Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome Mickael Beraud, Sabria Al Hashami, Miquel Lozano, Aicha Bah, Philip Keith
35 [GO] 2022―Mar―15 The feasibility of multiple units of convalescent plasma in mechanically ventilated patients with COVID-19: A pilot study Noah M. Merin, Alexis A. LeVee, Christian A. Merlo, Kellie Spector, Hannah Coleman, Ellen Klapper, et al. (+8)
36 [GO] 2022―Mar―12 Angiotensin (1-7) peptide replacement therapy with plasma transfusion in COVID-19 Hasan Onal, Nurcan Ucuncu Ergun, Bengu Arslan, Seyma Topuz, Seda Yilmaz Semerci, Osman Mutluhan Ugurel, et al. (+5)
37 [GO] 2022―Mar―05 Using Automation to Manage Donor Engagement and Fine-Tune Supply and Demand During the First Year of the COVID-19 Pandemic Theresa Pina, Marc Lewis, Charity Garrison, Anna Razatos
38 [GO] 2022―Feb―16 SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment Alessandro Ferrari, Irene Cassaniti, Josè Camilla Sammartino, Cristina Mortellaro, Claudia Del Fante, Simona De Vitis, et al. (+6)
39 [GO] 2022―Jan―31 Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico Victor Monteón, Floribeth Leon Pérez, Virginia Peña Hernández, Anatalia Osorio Pacheco, Pedro Fuentes Guzman, Gicel Ivett Gutiérrez Torres
40 [GO] 2022―Jan―17 Role of the AB0 blood group in COVID-19 infection and complications: A population-based study Mónica Enguita-Germán, Julián Librero, Leire Leache, Marta Gutiérrez-Valencia, Ibai Tamayo, Carlos Jericó, et al. (+2)
41 [GO] 2022―Jan―13 Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients Mickael Beraud, Erin Goodhue Meyer, Miquel Lozano, Aicha Bah, Ralph Vassallo, Bethany L. Brown
42 [GO] 2022―Jan―13 The impact of blood campaigns using mobile blood collection drives on blood supply management during the COVID-19 pandemic Amr J. Halawani
43 [GO] 2021―Dec―08 COVID-19-associated Evans syndrome: A case report and review of the literature Atakan Turgutkaya, Ali Zahit Bolaman, İrfan Yavaşoğlu
44 [GO] 2021―Dec―06 Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study Ram Jaiswal, Shweta Sharma, Ashina Singla, Nimisha Devpura, Rajat Vohra, Munish Kakkar, et al. (+2)
45 [GO] 2021―Nov―24 Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19 Alieh Fazeli, Shahin Sharifi, Fatemeh Behdad, Shamsi Okati, Gilda Esmaielifar, Nooshin Jelveh, et al. (+2)
46 [GO] 2021―Nov―23 SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors Judith Leon, Anna E. Merrill, Kai Rogers, Julie Kurt, Spencer Dempewolf, Alexandra Ehlers, et al. (+2)
47 [GO] 2021―Oct―29 The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection Alieh Fazeli, Shahin Sharifi, Saeed Mohammadi, Mehran Bahraini, Ali Arabkhazaeli, Nooshin Jelveh, Peyman Eshghi
48 [GO] 2021―Oct―22 Blood shortages and changes to massive transfusion protocols: Survey of hospital practices during the COVID-19 pandemic Jeremy W. Jacobs, Garrett S. Booth
49 [GO] 2021―Oct―16 Acute pancreatitis due to severe hypertriglyceridemia in the COVID-19 era: the role of Therapeutic Plasma Exchange Francesca Pavanello, Anna Colpo, Tiziana Tison, Roberto Fabris, Giustina De Silvestro, Piero Marson
50 [GO] 2021―Sep―21 Implementation of Maximum Surgical Blood Ordering Schedule in A Tertiary Hospital in Malaysia during COVID-19 Pandemic Tan Pei Pei, Jernih Abdul Rahman, Sarah Mat Noh, Irni Mohd Yasin, Sabariah Mohd Noor
51 [GO] 2021―Sep―17 Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 - a case series Johanna Erber, Johannes R. Wiessner, Christina Huberle, Jochen Schneider, Hrvoje Mijočević, Doris von Bomhard, et al. (+4)
52 [GO] 2021―Aug―17 Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 2021 Marte Hvalryg, Lise Sofie H. Nissen-Meyer
53 [GO] 2021―Aug―17 Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients Tuğçe Nur Yiğenoğlu, Semih Başcı, Derya Şahin, Turgay Ulaş, Mehmet Sinan Dal, Serdal Korkmaz, et al. (+5)
54 [GO] 2021―Aug―10 SHOULD TIMING BE CONSIDERED BEFORE ABANDONING CONVALESCENT PLASMA IN COVID-19? RESULTS FROM THE TURKISH EXPERIENCE İhsan Ateş, Abdulsamet Erden, Serdar Can Güven, Elif Kübra Gürler, Adem Çağlayan, Özge Güçbey, et al. (+6)
55 [GO] 2021―Jul―30 The association of ABO blood group with the asymptomatic COVID-19 cases in India Prajjval Pratap Singh, Abhishek K. Srivastava, Sudhir K. Upadhyay, Ashish Singh, Shashank Upadhyay, Pradeep Kumar, et al. (+3)
56 [GO] 2021―Jul―06 Awareness about Coronavirus (COVID-19) and challenges for blood services among potential blood donors Saud Almalki, Mohamed Asseri, Yahya Khawaji, Riad Alqurashi, Maha Badawi, Nehal Yakout, et al. (+2)
57 [GO] 2021―Jun―26 A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic Pelin Esme, Semanur Coban, Bilge Ugur, Meltem Aylı, Ercan Caliskan
58 [GO] 2021―Jun―15 COVID-19 antibody donation using immunoadsorption: Report of two cases Jannik Rothenburg, Silke Rink-Baron, Lisa Mueller, Philipp Niklas Ostermann, Johannes Fischer, Johannes Stegbauer, Anja Moldenhauer
59 [GO] 2021―Jun―10 Ubiquitous Convalescent Plasma: An Artificial Universal Plasma for COVID-19 Patients Mahla Sattarzadeh Bardsiri, Seyedeh Mehrnaz Kouhbananinejad, Reza Vahidi, Saeed Soleimany, Masoud Moghadari, Ali Derakhshani, et al. (+2)
60 [GO] 2021―Jun―03 Sequential Dosing of Convalescent COVID-19 Plasma with Significant Temporal Clinical Improvements in a Persistently SARS-COV-2 positive Patient Noupama Mirihagalle, Priyanka Parajuli, Vidya Sundareshan, Debadoot Saha, Arpan Shah, Francine Chua, et al. (+6)
61 [GO] 2021―Jun―03 Blood donor deferral periods after COVID-19 vaccination Abhaykumar Malind Gupta
62 [GO] 2021―May―26 Use Of Face Mask By Blood Donors During The Covid 19 Pandemic: Impact On Donor Hemoglobin Concentration: A Bane Or A Boon Rasika Setia, Mitu Dogra, Anil Handoo, Ramesh Yadav, Gokhula Prasath Thangavel, Amena Ebadur Rahman
63 [GO] 2021―May―23 Commentary: Convalescent plasma to treat COVID-19: Following the Argentinian lead Pierre Tiberghien, Eric Toussirot, Pascale Richard, Pascal Morel, Olivier Garraud
64 [GO] 2021―May―21 Systematic Review and Meta-analysis of the Susceptibility of ABO Blood Group to COVID-19 Infection Saeed M Kabrah, Ahmad Kabrah, Arwa F Flemban, Samer Abuzerr
65 [GO] 2021―May―08 Efficacy of Convalescent Plasma Therapy in Severe COVID-19 Patients Hilal Akay Cizmecioglu, Mevlut Hakan Goktepe, Sinan Demircioglu, Atakan Tekinalp, Ahmet Cizmecioglu, Ali Kursat Tuna, Huseyin Ozer
66 [GO] 2021―Apr―24 Effects On Mortality Of Early Vs Late Administration Of Convalescent Plasma In The Treatment Of Covid-19 Havva Kocayiğit, Gürkan Demir, Alper Karacan, Kezban Özmen Süner, Yakup Tomak, Selçuk Yaylacı, et al. (+3)
67 [GO] 2021―Apr―20 Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients Elham Roshandel, Ghazaleh Sankanian, Maryam Salimi, Arsalan Jalili, Sina Salari, Amir Sadeghi, et al. (+4)
68 [GO] 2021―Apr―19 Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine Cinzia Sissa, Ahmad Al-Khaffaf, Francesco Frattini, Roberta Gaiardoni, Elda Mimiola, Paolo Montorsi, et al. (+4)
69 [GO] 2021―Apr―16 Survey based cross-sectional study to analyse the variation of practices at blood centres during COVID-19 pandemic in India Abhishekh Basavarajegowda, Meenu Bajpai, Satyam Arora, Ashish Maheshwari, Seema Dua, Dibyajyoti Sahoo
70 [GO] 2021―Apr―03 COVID-19 related callback in blood donors; outcomes in blood donors and patients Sahar Balagholi, Mahtab Maghsudlu, Sedigheh Amini-Kafiabad, Amir Masoud Nazemi, Maryam Sotoudeh Anvari
71 [GO] 2021―Mar―02 Convalescent Blood Plasma (CBP) Donated by Recovered COVID-19 Patients - A comment Th. Lung, B. Sakem, M. Risch, U. Nydegger
72 [GO] 2021―Feb―27 Treating Thrombotic Thrombocytopenic Purpura Without Plasma Exchange During the COVID-19 Pandemic. A Case Report and a Brief Literature Review César David Galindo-Calvillo, Carlos Saúl Rodríguez-Roque, Andrés Gómez-De León, Luz Tarín-Arzaga, David Gómez-Almaguer
73 [GO] 2021―Feb―21 TWO PATIENTS WITH RITUXIMAB ASSOCIATED LOW GAMMAGLOBULIN LEVELS AND RELAPSED COVID-19 INFECTIONS TREATED WITH CONVALESCENT PLASMA Irati Ormazabal Vélez, Juan Induráin Bermejo, José Espinoza Pérez, Laura Imaz Aguayo, Marina Delgado Ruiz, José Antonio García-Erce
74 [GO] 2021―Feb―21 Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies Carlo Gambacorti-Passerini, Marco Ruggeri, Andrea Aroldi, Rocco Piazza, Angela Mazzi, Giustina De Silvestro, et al. (+2)
75 [GO] 2021―Feb―18 Changes in blood donation and utilization secondary to Covid-19 outbreak Carla L. Dinardo, Monica J. Vieira, Vanderson Rocha, Alfredo Mendrone-Júnior
76 [GO] 2021―Feb―17 The Story of an Extraordinary Year: Challenges and Opportunities in Responding to Covid-19 Lise Sofie H. Nissen-Meyer, Arne Broch Brantsæter
77 [GO] 2021―Feb―15 Immunotherapy for COVID-19: Evolving Treatment of Viral Infection and Associated Adverse Immunological Reactions Jeffrey S. Putter
78 [GO] 2021―Feb―10 People with blood disorders can be more vulnerable during COVID-19 pandemic: A Hypothesis Paper Duygu Aydemir, Nuriye Nuray Ulusu
79 [GO] 2021―Feb―05 Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies Preethi Jeyaraman, Narendra Agrawal, Rahul Bhargava, Divya Bansal, Rayaz Ahmed, Dinesh Bhurani, et al. (+4)
80 [GO] 2021―Jan―27 COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review Daniele Focosi, Massimo Franchini
81 [GO] 2021―Jan―22 Iatrogenic anaemia and transfusion thresholds in ICU patients with COVID-19 disease at a tertiary care hospital Ivo Beverina, Erika Borotto, Chiara Novelli, Danilo Radrizzani, Bruno Brando
82 [GO] 2021―Jan―14 A Look-Back at Convalescent Plasma to Treat COVID-19 Olivier Garraud, Karine Lacombe, Pierre Tiberghien
83 [GO] 2021―Jan―14 New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic Jerard Seghatchian
84 [GO] 2021―Jan―14 New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic Jerard Seghatchian
85 [GO] 2021―Jan―02 Analysis of blood donors’ characteristics and deferrals related to COVID-19 in Iran Mohammad Hessam Rafiee, Sedigheh Amini Kafiabad, Mahtab Maghsudlu
86 [GO] 2020―Dec―23 THE USE OF CONVALESCENT PLASMA FOR PEDIATRIC PATIENTS WITH SARS-COV-2: A SYSTEMATIC LITERATURE REVIEW Marco Zaffanello, Giorgio Piacentini, Luana Nosetti, Massimo Franchini
87 [GO] 2020―Nov―26 Transfusion practices during the COVID-19 pandemic: an experience from a hematology daycare in India Jayastu Senapati, Mukul Aggarwal, Liji Louis, Salim Mirza, Pradeep Kumar, Rishi Dhawan, et al. (+7)
88 [GO] 2020―Nov―24 Taking on a pandemic's challenge: Emergent solutions from a single Hemophlia treatment center in North India Nita Radhakrishnan, Ravi Shankar, Savitri Singh, Megha Rana
89 [GO] 2020―Nov―20 Convalescent plasma therapy in patients with COVID-19 Fevzi Altuntas, Tugce Nur Yigenoglu, Semih Bascı, Mehmet Sinan Dal, Serdal Korkmaz, Burhan Turgut, Mehmet Ali Erkurt
90 [GO] 2020―Nov―19 Convalescent Plasma (CP) Therapy in Patients with COVID-19 Banu Cakir
91 [GO] 2020―Nov―05 A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma Behzad Einollahi, Luca Cegolon, Hassan Abolghasemi, Sina Imanizadeh, Ali Bahramifar, Shi Zhao, et al. (+2)
92 [GO] 2020―Nov―02 Potential of Therapeutic Plasmapheresis in Treatment of COVID-19 Patients: Immunopathogenesis and Coagulopathy Sahar Balagholi, Rasul Dabbaghi, Peyman Eshghi, Seyed Asadollah Mousavi, Farhad Heshmati, Saeed Mohammadi
93 [GO] 2020―Nov―01 SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation Dmitry Balashov, Pavel Trakhtman, Anna Livshits, Irina Kovalenko, Galina Tereshenko, Galina Solopova, et al. (+3)
94 [GO] 2020―Oct―31 Blood supply management during the Covid-19 pandemic: Experience in a tertiary referral hospital in Malaysia Tan Pei Pei, Chang Chee Tao, Sabariah Mohd Noor
95 [GO] 2020―Oct―07 COVID-19: Further evidence of no transfusion transmission José Roberto Luzzi, Roberta Navarro, Carla Luana Dinardo
96 [GO] 2020―Sep―28 The effect of the COVID-19 pandemic on the adequacy of blood supply: Specialists in Transfusion Medicine need to establish models of preparedness Erasmia Rouka
97 [GO] 2020―Sep―25 Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia Ravi Shankar, Nita Radhakrishnan, Seema Dua, Satyam Arora, Megha Rana, Dinesh Kumar Sahu, et al. (+2)
98 [GO] 2020―Sep―20 Promoting access to COVID-19 convalescent plasma in low- and middle-income countries Evan M. Bloch, Ruchika Goel, Celina Montemayor, Claudia Cohn, Aaron A.R. Tobian
99 [GO] 2020―Sep―19 Convalescent Plasma Therapy in Patients with COVID-19 Fevzi Altuntas, Naim Ata, Tugce Nur Yigenoglu, Semih Bascı, Mehmet Sinan Dal, Serdal Korkmaz, et al. (+16)
100 [GO] 2020―Sep―06 A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19 Thomas Lung, Michel D. Kazatchkine, Lorenz Risch, Martin Risch, Urs E. Nydegger
101 [GO] 2020―Sep―06 Nurse’s perspective: The effects of Covid-19 in apheresis Lidia Yanchuk, Sue Sinclair, Sandy Pettman, Kari Lukianow
102 [GO] 2020―Sep―04 An Update on COVID-19 Infection Control Measures, Plasma-Based Therapeutics, Corticosteroid Pharmacotherapy and Vaccine Research Jeffrey S. Putter, Jerard Seghatchian
103 [GO] 2020―Sep―03 Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!! Jerard Seghatchian, Jason P. Acker, Jeffery S. Putter
104 [GO] 2020―Sep―01 Response Letter: Treatment for emerging viruses: Convalescent plasma and COVID-19 Bethany Brown
105 [GO] 2020―Aug―28 Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection Timotius Ivan Hariyanto, Andree Kurniawan
106 [GO] 2020―Aug―27 Convalescent plasma for COVID-19 considerations Jeanne Adiwinata Pawitan
107 [GO] 2020―Aug―27 Convalescent Plasma as a Treatment Modality for Coronavirus Disease 2019 in Sudan Mozan Osman Hassan, Asma Ahmed Osman, Hana Elsir Abd Elbasit, Hanan Elsamani Hassan, Hala Rufai, Maria M.M. Satti, et al. (+8)
108 [GO] 2020―Aug―25 The successful management of an elderly Covid-19 infected patient by plasmapheresis Yasemin Akkoyunlu, Guven Cetin, Sibel Bolukcu, Gulay Okay, Hamza Ogun, Bulent Durdu, et al. (+2)
109 [GO] 2020―Aug―25 IMPACT OF COVID-19 PANDEMIC IN THE ACTIVITY OF A THERAPEUTIC APHERESIS UNIT IN ITALY A. Colpo, L. Astolfi, T. Tison, G. De Silvestro, P. Marson
110 [GO] 2020―Aug―25 SARS-CoV-2 Serology and Virology Trends in Donors and Recipients of Convalescent Plasma Latha Dulipsingh, Danyal Ibrahim, Ernst J. Schaefer, Rebecca Crowell, Margaret R. Diffenderfer, Kendra Williams, et al. (+10)
111 [GO] 2020―Aug―24 No transmission of SARS-CoV-2 in a patient undergoing allogeneic Hematopoietic Cell Transplantation from a matched-related donor with unknown COVID-19 P. Lázaro del Campo, A. Ramírez López, B. de la Cruz Benito, R. de Paz Arias, K. Humala Barbier, I. Sánchez Vadillo, et al. (+4)
112 [GO] 2020―Aug―24 SEROPREVALENCE OF SARS-COV-2 ANTIBODIES AMONG HEALTHY BLOOD DONORS IN KARACHI, PAKISTAN Amber Younas, Samra Waheed, Shabnum Khawaja, Mehjabeen Imam, Munira Borhany, Tahir Shamsi
113 [GO] 2020―Aug―04 Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia Erhan Tatar, Murat Karatas, Ilter Bozaci, Alpay Ari, Turker Acar, Cenk Simsek, et al. (+3)
114 [GO] 2020―Aug―03 Covid-19-induced coagulopathy and observed benefits with anticoagulation Sedighe Karimzade, Vinh Dong, Osama Gamal Hassan, Akshay Raut, Ahmed Fouda, Allison Parrill, et al. (+2)
115 [GO] 2020―Jul―16 Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario Priyadarsini J. Arcot, Karan Kumar, Tapasyapreeti Mukhopadhyay, Arulselvi Subramanian
116 [GO] 2020―Jul―15 Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study Hassan Abolghasemi, Peyman Eshghi, Abdol Majid Cheraghali, Abbas Ali Imani Fooladi, Farzaneh Bolouki Moghaddam, Sina Imanizadeh, et al. (+21)
117 [GO] 2020―Jul―15 Organization of the outdoor blood donation drives amid novel coronavirus pandemic and national lockdown: An experience from a tertiary care oncology institution in India Abhaykumar Malind Gupta, Shashank Ojha, Minal Poojary, Sumathi S.H., P. Nagaraju, Rajendra Dhokle
118 [GO] 2020―Jul―03 Prolonged Viral Shedding in a Lymphoma Patient with COVID-19 Infection Receiving Convalescent Plasma Ayşe Karataş, Ahmet Çağkan İnkaya, Haluk Demiroğlu, Salih Aksu, Tahmaz Haziyev, Olgu Erkin Çınar, et al. (+4)
119 [GO] 2020―Jul―01 Challenges in platelet inventory management at a tertiary care oncology center during the novel coronavirus disease (COVID-19) pandemic lockdown in India Shashank Ojha, Abhaykumar Malind Gupta, P. Nagaraju, Poojary Minal, Sumathi S.H.
120 [GO] 2020―Jul―01 First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia Magdalena Figlerowicz, Anna Mania, Karol Lubarski, Zuzanna Lewandowska, Wojciech Służewski, Katarzyna Derwich, et al. (+2)
121 [GO] 2020―Jun―27 Immunomodulation for the Management of Corona Virus Disease (COVID-19) Dobri Kiprov, Michael J. Conboy, Irina M. Conboy
122 [GO] 2020―Jun―27 Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia Mehmet Ali Erkurt, Ahmet Sarici, İlhami Berber, İrfan Kuku, Emin Kaya, Mustafa Özgül
123 [GO] 2020―Jun―27 Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials? Olivier Garraud
124 [GO] 2020―Jun―26 Editorial: Information on the COVID-19 Pandemic continued. Gail Rock
125 [GO] 2020―Jun―25 Extracorporeal Blood Purification Treatment Options for COVID-19: The Role of Immunoadsorption Tuğçe Nur Yiğenoğlu, Turgay Ulas, Mehmet Sinan Dal, Serdal Korkmaz, Mehmet Ali Erkurt, Fevzi Altuntaş
126 [GO] 2020―Jun―04 Regulatory Consideration on Preparation and Clinical Use of COVID-19 Convalescent Plasma Yılmaz Soner, Ertuğrul Örüç Nigar, Azap Alpay, Özcebe Osman, Çetin Türker, Yenicesu İdil, et al. (+3)
127 [GO] 2020―Jun―04 Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia Amar Ibrahim Omer Yahia
128 [GO] 2020―Jun―03 COVID-19 and the ABO blood group connection Fatima Zia Zaidi, Abdul Rehman Zia Zaidi, Syed Maaz Abdullah, Syed Ziauddin Ahmed Zaidi
129 [GO] 2020―Jun―03 Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies Ying Li, Shanglong Liu, Shuchao Zhang, Qiang Ju, Shaoqiang Zhang, Yuanming Yang, Haiyan Wang
130 [GO] 2020―May―29 Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis Olgu Erkin Çınar, Başak Sayınalp, Elifcan Aladağ Karakulak, Ayşe Avşar Karataş, Mustafa Velet, Ahmet Çağkan İnkaya, et al. (+6)
131 [GO] 2020―May―21 Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19 Accorsi Patrizia, Berti Pierluigi, de Angelis Vincenzo, De Silvestro Giustina, Mascaretti Luca, Ostuni Angelo
132 [GO] 2020―May―21 Dwindling blood reserves: An ominous downside of COVID-19 pandemic Sohail Kumar, Dua Azim, Sundus Nasim, Shariq Haider Hashmi
133 [GO] 2020―May―21 Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma Yujie Kong, Chen Cai, Li Ling, Li Zeng, Meihong Wu, Yanyun Wu, et al. (+2)
134 [GO] 2020―May―04 Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients? Jean Amiral, Anne Marie Vissac, Jerard Seghatchian
135 [GO] 2020―Apr―23 Theme: information on the Covid-19 Pandemic Gail Rock
136 [GO] 2020―Apr―21 TreaTment for emerging viruses: Convalescent plasma and COVID-19 Bethany L. Brown, Jeffrey McCullough
137 [GO] 2020―Apr―21 COVID-19: A Perspective of a Frontline Worker Emy Cowlan
 [1] 

137 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec